Syndax Pharmaceuticals Inc. monthly returns
Syndax Pharmaceuticals Inc. has averaged 2.15% per month, positive in 50% of months. Month-by-month returns for Syndax Pharmaceuticals Inc. (SNDX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Syndax Pharmaceuticals Inc. monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -31.4% | |
| Sep 2026 | -2.5% | |
| Aug 2026 | +1.3% | |
| Jul 2026 | -12.9% | |
| Jun 2026 | +11.6% | |
| May 2026 | -8.6% | |
| Apr 2026 | -8.3% | |
| Mar 2026 | +7.6% | |
| Feb 2026 | +6.9% | |
| Jan 2026 | -3.3% | |
| Dec 2025 | +6.0% | |
| Nov 2025 | +44.7% | |
| Oct 2025 | -11.0% | |
| Sep 2025 | -5.8% | |
| Aug 2025 | +64.6% | |
| Jul 2025 | +5.9% | |
| Jun 2025 | -11.1% | |
| May 2025 | -25.5% | |
| Apr 2025 | +15.2% | |
| Mar 2025 | -21.5% | |
| Feb 2025 | +10.4% | |
| Jan 2025 | +7.2% | |
| Dec 2024 | -20.9% | |
| Nov 2024 | -11.3% | |
| Oct 2024 | -2.0% | |
| Sep 2024 | -6.3% | |
| Aug 2024 | -9.5% | |
| Jul 2024 | +10.6% | |
| Jun 2024 | +6.5% | |
| May 2024 | -8.8% | |
| Apr 2024 | -11.2% | |
| Mar 2024 | +1.5% | |
| Feb 2024 | +14.4% | |
| Jan 2024 | -5.2% | |
| Dec 2023 | +29.8% | |
| Nov 2023 | +18.2% | |
| Oct 2023 | -3.0% | |
| Sep 2023 | -21.6% | |
| Aug 2023 | -13.2% | |
| Jul 2023 | +1.9% | |
| Jun 2023 | +4.8% | |
| May 2023 | -2.8% | |
| Apr 2023 | -2.7% | |
| Mar 2023 | -16.7% | |
| Feb 2023 | -11.7% | |
| Jan 2023 | +12.8% | |
| Dec 2022 | +6.2% | |
| Nov 2022 | +4.4% | |
| Oct 2022 | -4.5% | |
| Sep 2022 | +1.8% | |
| Aug 2022 | +15.9% | |
| Jul 2022 | +5.9% | |
| Jun 2022 | +16.6% | |
| May 2022 | -1.6% | |
| Apr 2022 | -3.5% | |
| Mar 2022 | +11.5% | |
| Feb 2022 | -4.6% | |
| Jan 2022 | -25.4% | |
| Dec 2021 | +37.1% | |
| Nov 2021 | -17.9% | |
| Oct 2021 | +1.8% | |
| Sep 2021 | +9.3% | |
| Aug 2021 | +20.0% | |
| Jul 2021 | -15.1% | |
| Jun 2021 | -6.5% | |
| May 2021 | +15.2% | |
| Apr 2021 | -28.7% | |
| Mar 2021 | -8.4% | |
| Feb 2021 | +21.8% | |
| Jan 2021 | -9.9% | |
| Dec 2020 | -4.0% | |
| Nov 2020 | +33.1% | |
| Oct 2020 | +18.0% | |
| Sep 2020 | -9.5% | |
| Aug 2020 | +15.6% | |
| Jul 2020 | -4.8% | |
| Jun 2020 | -8.5% | |
| May 2020 | -10.0% | |
| Apr 2020 | +64.1% | |
| Mar 2020 | +16.6% | |
| Feb 2020 | +0.3% | |
| Jan 2020 | +6.8% | |
| Dec 2019 | +20.4% | |
| Nov 2019 | +8.5% | |
| Oct 2019 | -10.0% | |
| Sep 2019 | -11.2% | |
| Aug 2019 | -12.4% | |
| Jul 2019 | +3.1% | |
| Jun 2019 | +27.5% | |
| May 2019 | +2.1% | |
| Apr 2019 | +36.2% | |
| Mar 2019 | -14.9% | |
| Feb 2019 | +10.2% | |
| Jan 2019 | +25.8% | |
| Dec 2018 | -12.7% | |
| Nov 2018 | +6.0% | |
| Oct 2018 | -40.5% | |
| Sep 2018 | +4.1% | |
| Aug 2018 | +15.1% | |
| Jul 2018 | -4.0% | |
| Jun 2018 | -19.6% | |
| May 2018 | -16.4% | |
| Apr 2018 | -26.6% | |
| Mar 2018 | +57.4% | |
| Feb 2018 | -17.1% | |
| Jan 2018 | +24.4% | |
| Dec 2017 | +0.0% | |
| Nov 2017 | -21.6% | |
| Oct 2017 | -4.4% | |
| Sep 2017 | +0.9% | |
| Aug 2017 | -4.2% | |
| Jul 2017 | -13.3% | |
| Jun 2017 | +15.1% | |
| May 2017 | +27.9% | |
| Apr 2017 | -30.8% | |
| Mar 2017 | +20.6% | |
| Feb 2017 | +49.7% | |
| Jan 2017 | +6.0% | |
| Dec 2016 | -25.9% | |
| Nov 2016 | -18.0% |
Monthly total return (since Nov 2021)#
Syndax Pharmaceuticals Inc. returns by calendar month#
Every month of every year since 2017, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -31.38% — 9th of 10 Octobers since 2017 at the last close; the average October returned -6.2%.
| Month | −65%0+65% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +3.9% | +6.4% | 60% | +25.8% 2019 | -25.4% 2022 | |
| Feb | +8.0% | +8.5% | 70% | +49.7% 2017 | -17.1% 2018 | |
| Mar | +5.4% | +4.6% | 60% | +57.4% 2018 | -21.5% 2025 | |
| Apr | +0.4% | -5.9% | 30% | +64.1% 2020 | -30.8% 2017 | |
| May | -2.8% | -5.7% | 30% | +27.9% 2017 | -25.5% 2025 | |
| Jun | +3.6% | +5.7% | 60% | +27.5% 2019 | -19.6% 2018 | |
| Jul | -2.3% | -1.1% | 50% | +10.6% 2024 | -15.1% 2021 | |
| Aug | +9.3% | +8.2% | 60% | +64.6% 2025 | -13.2% 2023 | |
| Sep | -4.1% | -4.2% | 40% | +9.3% 2021 | -21.6% 2023 | |
| Oct | -6.2% | -4.4% | 22% | +18.0% 2020 | -40.5% 2018 | |
| Nov | +7.1% | +6.0% | 67% | +44.7% 2025 | -21.6% 2017 | |
| Dec | +6.9% | +6.0% | 56% | +37.1% 2021 | -20.9% 2024 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from SNDX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Syndax Pharmaceuticals Inc.'s average monthly return?
- Syndax Pharmaceuticals Inc. (SNDX) has averaged about 2.15% per month, positive in roughly 50% of months. The best month was Aug 2025 (+64.6%) and the worst was Oct 2018 (-40.5%).
